The beta2 receptor and airway hyper-responsiveness: are sensory nerves involved?

training levels. Eur J Radiol 2007;64:285–95. 9. Shinagawa N, Yamazaki K, Onodera Y, et al. Factors related to diagnostic sensitivity using an ultrathin bronchoscope under CT guidance. Chest 2007;131:549–53. 10. Vincent BD, Fraig M, Silvestri GA. A pilot study of narrow-band imaging compared to white light bronchoscopy for evaluation of normal airways and premalignant and malignant airways disease. Chest 2007;131:1794–9. 11. Coxson HO, Quiney B, Sin DD, et al. Airway wall thickness assessed using computed tomography and optical coherente tomography. Am J Respir Crit Care Med 2008;177:1201–6. 12. Shedden K, Taylor JMG, Enkemann SA, et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 2008;14:822–7. 13. Spira A, Beane JE, Shah V, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007;13:361–6. 14. Yanagisawa K, Shyr Y, Xu BJ, et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003;362:433–9. 15. Yildiz PB, Shyr Y, Rahman JSM, et al. Diagnostic accuracy of MALDI mass spectrometric análysis of unfractionated serum in lung cancer. J Thorac Oncol 2007;2:893–901. 16. Brock MV, Hooker CM, Ota-Machida E, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 2008;358:1118–28. 17. Maheswaran S, Sequist LV, Nagrath S, et al. Detection of mutations in EGFR in circulating lungcancer cells. N Engl J Med 2008;359:1–12. 18. Chapman CJ, Murray A, McElveen JE, et al. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 2008;63:228–33. 19. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997–1006. 20. Carpagnano GE, Foschino-Barbaro MP, Spanevello A, et al. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer. Am J Respir Crit Care Med 2008;177:337–41. 21. Mazzone PJ. Analysis of volatile organic compounds in the exhaled breath for lung cancer diagnosis. J Thorac Oncol 2008;3:774–80. 22. Westhoff M, Litterst P, Freitag L, et al. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 2009;64:744–8.